BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei Y, Yang P, Cao S, Zhao L. The combination of curcumin and 5-fluorouracil in cancer therapy. Arch Pharm Res 2018;41:1-13. [PMID: 29230689 DOI: 10.1007/s12272-017-0979-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Wu CF, Wu CY, Chiou RY, Yang WC, Lin CF, Wang CM, Hou PH, Lin TC, Kuo CY, Chang GR. The Anti-Cancer Effects of a Zotarolimus and 5-Fluorouracil Combination Treatment on A549 Cell-Derived Tumors in BALB/c Nude Mice. Int J Mol Sci 2021;22:4562. [PMID: 33925400 DOI: 10.3390/ijms22094562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ravindranathan P, Pasham D, Balaji U, Cardenas J, Gu J, Toden S, Goel A. A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer. Sci Rep 2018;8:13869. [PMID: 30218018 DOI: 10.1038/s41598-018-32267-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
3 Zhao S, Pi C, Ye Y, Zhao L, Wei Y. Recent advances of analogues of curcumin for treatment of cancer. Eur J Med Chem 2019;180:524-35. [PMID: 31336310 DOI: 10.1016/j.ejmech.2019.07.034] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
4 Steel TR, Walsh F, Wieczorek-błauż A, Hanif M, Hartinger CG. Monodentately-coordinated bioactive moieties in multimodal half-sandwich organoruthenium anticancer agents. Coordination Chemistry Reviews 2021;439:213890. [DOI: 10.1016/j.ccr.2021.213890] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
5 Chang GR, Kuo CY, Tsai MY, Lin WL, Lin TC, Liao HJ, Chen CH, Wang YC. Anti-Cancer Effects of Zotarolimus Combined with 5-Fluorouracil Treatment in HCT-116 Colorectal Cancer-Bearing BALB/c Nude Mice. Molecules 2021;26:4683. [PMID: 34361836 DOI: 10.3390/molecules26154683] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Shimura T, Sharma P, Sharma GG, Banwait JK, Goel A. Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer. Sci Rep 2021;11:7548. [PMID: 33824419 DOI: 10.1038/s41598-021-87283-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Divella R, Daniele A, Savino E, Paradiso A. Anticancer Effects of Nutraceuticals in the Mediterranean Diet: An Epigenetic Diet Model. Cancer Genomics Proteomics 2020;17:335-50. [PMID: 32576579 DOI: 10.21873/cgp.20193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
8 Zhang C, Fu S, Zhang F, Han M, Wang X, Du J, Zhang H, Li W. Affibody Modified G-quadruplex DNA Micelles Incorporating Polymeric 5-Fluorodeoxyuridine for Targeted Delivery of Curcumin to Enhance Synergetic Therapy of HER2 Positive Gastric Cancer. Nanomaterials 2022;12:696. [DOI: 10.3390/nano12040696] [Reference Citation Analysis]
9 Tian JH, Liu SH, Yu CY, Wu LG, Wang LB. The Role of Non-Coding RNAs in Breast Cancer Drug Resistance. Front Oncol 2021;11:702082. [PMID: 34589423 DOI: 10.3389/fonc.2021.702082] [Reference Citation Analysis]
10 Luo R-, Mao S-, Liu C-, Zhou Z-, Huang Z-. SYNTHESIS, X-RAY STRUCTURE ANALYSIS, AND VIBRATIONAL SPECTRAL STUDIES OF 1-(3-((6-BROMOPYRIDO[2,3-d]PYRIMIDIN-4-YL) OXY)PHENYL)-3-CYCLOPENTYLUREA. J Struct Chem 2022;63:37-51. [DOI: 10.1134/s002247662201005x] [Reference Citation Analysis]
11 Amini Chermahini F, Raeisi E, Aazami MH, Mirzaei A, Heidarian E, Lemoigne Y. Does Bromelain-Cisplatin Combination Afford In-Vitro Synergistic Anticancer Effects on Human Prostatic Carcinoma Cell Line, PC3? Galen Med J 2020;9:e1749. [PMID: 34466585 DOI: 10.31661/gmj.v9i0.1749] [Reference Citation Analysis]
12 Liu G, Yang L, Chen G, Xu F, Yang F, Yu H, Li L, Dong X, Han J, Cao C, Qi J, Su J, Xu X, Li X, Li B. A Review on Drug Delivery System for Tumor Therapy. Front Pharmacol 2021;12:735446. [PMID: 34675807 DOI: 10.3389/fphar.2021.735446] [Reference Citation Analysis]
13 Falzone L, Salomone S, Libra M. Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium. Front Pharmacol. 2018;9:1300. [PMID: 30483135 DOI: 10.3389/fphar.2018.01300] [Cited by in Crossref: 192] [Cited by in F6Publishing: 174] [Article Influence: 48.0] [Reference Citation Analysis]
14 Liu Z, Cai C, Du J, Liu B, Cui L, Fan X, Wu Q, Fang J, Xie L. TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology. Front Pharmacol 2020;11:439. [PMID: 32351388 DOI: 10.3389/fphar.2020.00439] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Satari A, Amini SA, Raeisi E, Lemoigne Y, Heidarian E. Synergetic Impact of Combined 5-Fluorouracil and Rutin on Apoptosis in PC3 Cancer Cells through the Modulation of P53 Gene Expression. Adv Pharm Bull 2019;9:462-9. [PMID: 31592435 DOI: 10.15171/apb.2019.055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
16 Rakoczy K, Szlasa W, Sauer N, Saczko J, Kulbacka J. Molecular relation between biological stress and carcinogenesis. Mol Biol Rep 2022. [PMID: 35610338 DOI: 10.1007/s11033-022-07543-6] [Reference Citation Analysis]
17 Xu T, Guo P, Pi C, He Y, Yang H, Hou Y, Feng X, Jiang Q, Wei Y, Zhao L. Synergistic Effects of Curcumin and 5-Fluorouracil on the Hepatocellular Carcinoma In vivo and vitro through regulating the expression of COX-2 and NF-κB. J Cancer 2020;11:3955-64. [PMID: 32328199 DOI: 10.7150/jca.41783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
18 Raish M, Kalam MA, Ahmad A, Shahid M, Ansari MA, Ahad A, Ali R, Bin Jardan YA, Alshamsan A, Alkholief M, Alkharfy KM, Abdelrahman IA, Al-Jenoobi FI. Eudragit-Coated Sporopollenin Exine Microcapsules (SEMC) of Phoenix dactylifera L. of 5-Fluorouracil for Colon-Specific Drug Delivery. Pharmaceutics 2021;13:1921. [PMID: 34834336 DOI: 10.3390/pharmaceutics13111921] [Reference Citation Analysis]
19 Sanad MF, Shalan AE, Bazid SM, Abu Serea ES, Hashem EM, Nabih S, Ahsan MA. A graphene gold nanocomposite-based 5-FU drug and the enhancement of the MCF-7 cell line treatment. RSC Adv 2019;9:31021-9. [DOI: 10.1039/c9ra05669f] [Cited by in Crossref: 25] [Article Influence: 8.3] [Reference Citation Analysis]
20 Manogaran P, Beeraka NM, Padma VV. The Cytoprotective and Anti-cancer Potential of Bisbenzylisoquinoline Alkaloids from Nelumbo nucifera. CTMC 2020;19:2940-57. [DOI: 10.2174/1568026619666191116160908] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Wang D, Yu D, Liu X, Wang Q, Chen X, Hu X, Wang Q, Jin C, Wen L, Zhang L. Targeting laryngeal cancer cells with 5-fluorouracil and curcumin using mesoporous silica nanoparticles. Technol Cancer Res Treat 2020;19:1533033820962114. [PMID: 33267716 DOI: 10.1177/1533033820962114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Cui Z, Wang Q, Deng MH, Han QL. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis. Cancer Biomark 2021. [PMID: 34542064 DOI: 10.3233/CBM-210212] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Curcio M, Cirillo G, Tucci P, Farfalla A, Bevacqua E, Vittorio O, Iemma F, Nicoletta FP. Dextran-Curcumin Nanoparticles as a Methotrexate Delivery Vehicle: A Step Forward in Breast Cancer Combination Therapy. Pharmaceuticals (Basel) 2019;13:E2. [PMID: 31881645 DOI: 10.3390/ph13010002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
24 Mortezaee K, Salehi E, Mirtavoos-Mahyari H, Motevaseli E, Najafi M, Farhood B, Rosengren RJ, Sahebkar A. Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy. J Cell Physiol 2019;234:12537-50. [PMID: 30623450 DOI: 10.1002/jcp.28122] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 21.7] [Reference Citation Analysis]
25 Bachmeier BE, Killian PH, Melchart D. The Role of Curcumin in Prevention and Management of Metastatic Disease. Int J Mol Sci 2018;19:E1716. [PMID: 29890744 DOI: 10.3390/ijms19061716] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
26 Guo P, He Y, Xu T, Pi C, Jiang Q, Wei Y, Zhao L. Co-delivery system of chemotherapy drugs and active ingredients from natural plants: a brief overview of preclinical research for cancer treatment. Expert Opin Drug Deliv 2020;17:665-75. [PMID: 32149539 DOI: 10.1080/17425247.2020.1739647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Zheng Q, Li Q, Zhao G, Zhang J, Yuan H, Gong D, Guo Y, Liu X, Li K, Lin P. Alkannin induces cytotoxic autophagy and apoptosis by promoting ROS-mediated mitochondrial dysfunction and activation of JNK pathway. Biochemical Pharmacology 2020;180:114167. [DOI: 10.1016/j.bcp.2020.114167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Motieghader H, Tabrizi-nezhadi P, Deldar Abad Paskeh M, Baradaran B, Mokhtarzadeh A, Hashemi M, Lanjanian H, Jazayeri SM, Maleki M, Khodadadi E, Nematzadeh S, Kiani F, Maghsoudloo M, Masoudi-nejad A. Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug–gene interaction networks analysis. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-13719-8] [Reference Citation Analysis]
29 Park J, Lee GE, An HJ, Lee CJ, Cho ES, Kang HC, Lee JY, Lee HS, Choi JS, Kim DJ, Choi JS, Cho YY. Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells. Arch Pharm Res 2021. [PMID: 34750753 DOI: 10.1007/s12272-021-01358-y] [Reference Citation Analysis]
30 Sadeghi-abandansari H, Pakian S, Nabid M, Ebrahimi M, Rezalotfi A. Local co-delivery of 5-fluorouracil and curcumin using Schiff's base cross-linked injectable hydrogels for colorectal cancer combination therapy. European Polymer Journal 2021;157:110646. [DOI: 10.1016/j.eurpolymj.2021.110646] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
31 Haritha NH, Nawab A, Vijayakurup V, Anto NP, Liju VB, Alex VV, Amrutha AN, Aiswarya SU, Swetha M, Vinod BS, Sundaram S, Guijarro MV, Herlevich T, Krishna A, Nestory NK, Bava SV, Sadasivan C, Zajac-Kaye M, Anto RJ. Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy. Front Oncol 2021;11:656804. [PMID: 34336653 DOI: 10.3389/fonc.2021.656804] [Reference Citation Analysis]
32 Yi GY, Kim MJ, Kim HI, Park J, Baek SH. Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches. Antioxidants 2022;11:625. [DOI: 10.3390/antiox11040625] [Reference Citation Analysis]
33 Pani S, Mohapatra S, Sahoo A, Baral B, Debata PR. Shifting of cell cycle arrest from the S-phase to G2/M phase and downregulation of EGFR expression by phytochemical combinations in HeLa cervical cancer cells. J Biochem Mol Toxicol 2021;:e22947. [PMID: 34726804 DOI: 10.1002/jbt.22947] [Reference Citation Analysis]
34 Ershadi N, Safaiee R, Golshan M. Functionalized (4,0) or (8,0) SWCNT as novel carriers of the anticancer drug 5-FU; A first-principle investigation. Applied Surface Science 2021;536:147718. [DOI: 10.1016/j.apsusc.2020.147718] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
35 Sritharan S, Guha S, Hazarika S, Sivalingam N. Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance. Apoptosis 2022. [PMID: 35716277 DOI: 10.1007/s10495-022-01742-z] [Reference Citation Analysis]
36 Guan Y, Bhandari A, Zhang X, Wang O. Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines. J Cell Mol Med 2019;23:7438-48. [PMID: 31496029 DOI: 10.1111/jcmm.14612] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
37 Lindsay C, Kostiuk M, Conrad D, O’connell DA, Harris J, Seikaly H, Biron VL. Antitumour effects of metformin and curcumin in human papillomavirus positive and negative head and neck cancer cells. Mol Carcinog 2019;58:1946-59. [DOI: 10.1002/mc.23087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
38 Chen Y, Deng Y, Zhu C, Xiang C. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles. Biomed Pharmacother 2020;127:110181. [PMID: 32416561 DOI: 10.1016/j.biopha.2020.110181] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
39 Guo P, Pi C, Zhao S, Fu S, Yang H, Zheng X, Zhang X, Zhao L, Wei Y. Oral co-delivery nanoemulsion of 5-fluorouracil and curcumin for synergistic effects against liver cancer. Expert Opinion on Drug Delivery 2020;17:1473-84. [DOI: 10.1080/17425247.2020.1796629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Liu Z, Huang P, Law S, Tian H, Leung W, Xu C. Preventive Effect of Curcumin Against Chemotherapy-Induced Side-Effects. Front Pharmacol 2018;9:1374. [PMID: 30538634 DOI: 10.3389/fphar.2018.01374] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
41 Albuquerque C, Pebre Pereira L. Wnt Signalling-Targeted Therapy in the CMS2 Tumour Subtype: A New Paradigm in CRC Treatment? Adv Exp Med Biol 2018;1110:75-100. [PMID: 30623367 DOI: 10.1007/978-3-030-02771-1_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Gao Y, Chen DL, Zhou M, Zheng ZS, He MF, Huang S, Liao XZ, Zhang JX. Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway. Cell Death Dis 2020;11:866. [PMID: 33067427 DOI: 10.1038/s41419-020-03079-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Siemiaszko G, Niemirowicz-laskowska K, Markiewicz KH, Misztalewska-turkowicz I, Dudź E, Milewska S, Misiak P, Kurowska I, Sadowska A, Car H, Wilczewska AZ. Synergistic effect of folate-conjugated polymers and 5-fluorouracil in the treatment of colon cancer. Cancer Nano 2021;12. [DOI: 10.1186/s12645-021-00104-9] [Reference Citation Analysis]
44 Buhrmann C, Kunnumakkara AB, Popper B, Majeed M, Aggarwal BB, Shakibaei M. Calebin A Potentiates the Effect of 5-FU and TNF-β (Lymphotoxin α) against Human Colorectal Cancer Cells: Potential Role of NF-κB. Int J Mol Sci 2020;21:E2393. [PMID: 32244288 DOI: 10.3390/ijms21072393] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
45 Farghadani R, Naidu R. Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer. Int J Mol Sci 2022;23:2144. [PMID: 35216255 DOI: 10.3390/ijms23042144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Bárcenas-López DA, Mendiola-Soto DK, Núñez-Enríquez JC, Mejía-Aranguré JM, Hidalgo-Miranda A, Jiménez-Morales S. Promising genes and variants to reduce chemotherapy adverse effects in acute lymphoblastic leukemia. Transl Oncol 2021;14:100978. [PMID: 33290991 DOI: 10.1016/j.tranon.2020.100978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Arthur-baidoo E, Schöpfer G, Ončák M, Chomicz-mańka L, Rak J, Denifl S. Electron Attachment to 5-Fluorouracil: The Role of Hydrogen Fluoride in Dissociation Chemistry. IJMS 2022;23:8325. [DOI: 10.3390/ijms23158325] [Reference Citation Analysis]
48 Tan X, Zhang Z, Liu P, Yao H, Shen L, Tong JS. Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer. Cell Death Dis 2020;11:1061. [PMID: 33311453 DOI: 10.1038/s41419-020-03266-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]